Abeona Therapeutics
Commercializes ZEVASKYN for RDEB wounds through qualified treatment centers.
$5.97
After-hours close+0.04 (+0.67%)
At close$5.93(−1.82%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions —Insiders 6.30%
Shares outstanding 57.00M · Float 36.62M · 64.3% free float
Institutions13F
No 13F holders on record.
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Nantahala Capital Management, LLC | 9.99% | 5.78M | 13G | May 15, 2026 ↗ |
| Nantahala Capital Partners Limited Partnership | 5.82% | 3.33M | 13G | May 15, 2026 ↗ |
| BlackRock, Inc. | 5.80% | 2.95M | 13G | Jul 17, 2025 ↗ |
| Orin Hirschman | 5.40% | 3.10M | 13G | Apr 28, 2026 ↗ |
| Funicular Funds, LP | 5.30% | 3.01M | 13G | Apr 6, 2026 ↗ |
| James Russell Revocable Trust | 5.30% | 2.72M | 13G | Sep 30, 2025 ↗ |
| Suvretta Capital Management, LLC | 5.20% | 2.68M | 13G | Aug 13, 2025 ↗ |
| Daniel Kaufman | 5.16% | 2.94M | 13G | Mar 27, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Vishwas Seshadri | director, officer: Chief Executive Officer | 1.31M | 2.29% | Jul 9, 2026 |
| Joseph Walter Vazzano | officer: Chief Financial Officer | 492.1K | 0.86% | Jul 22, 2026 |
| Brendan M. O'Malley | officer: SVP, Chief Legal Officer | 428.0K | 0.75% | Jul 9, 2026 |
| Madhav Vasanthavada | officer: Chief Commercial Officer | 290.6K | 0.51% | Jul 9, 2026 |
| Michael Amoroso | director | 217.8K | 0.38% | Jan 27, 2026 |
| Faith L. Charles | director | 176.4K | 0.31% | Jan 27, 2026 |
| Donald A. Wuchterl | director | 167.9K | 0.29% | Feb 2, 2026 |
| Leila Alland | director | 162.6K | 0.29% | Jul 2, 2026 |
| Christine Berni Silverstein | director | 119.6K | 0.21% | Jun 15, 2026 |
| Bernhardt G. Zeiher | director | 84.5K | 0.15% | Jan 27, 2026 |
7 ten-percent owners hold 3.25M shares by Form 4, outside the officers-and-directors figure above · 19 people have not refiled in the last 18 months (555.7K shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jul 21, 2026 | Joseph Walter Vazzanoofficer: Chief Financial Officer | Sale | 1,478 | $6.53 | 492,079 |
| Jul 9, 2026 | Madhav Vasanthavadaofficer: Chief Commercial Officer | Sale | 12,606 | $6.96 | 290,623 |
| Jul 9, 2026 | Brendan M. O'Malleyofficer: SVP, Chief Legal Officer | Sale | 12,050 | $6.96 | 427,953 |
| Jul 9, 2026 | Vishwas Seshadridirector, officer: Chief Executive Officer | Sale | 67,971 | $6.96 | 1,306,108 |
| Jul 9, 2026 | Joseph Walter Vazzanoofficer: Chief Financial Officer | Sale | 24,880 | $6.96 | 493,557 |
| Jun 30, 2026 | Leila Allanddirector | Sale | 11,000 | $5.92 | 162,614 |
| Jun 15, 2026 | Christine Berni Silversteindirector | Sale | 18,160 | $5.71 | 119,562 |
| Jun 9, 2026 | Vishwas Seshadridirector, officer: Chief Executive Officer | Sale | 31,916 | $5.30 | 1,374,079 |
| Jun 8, 2026 | Vishwas Seshadridirector, officer: Chief Executive Officer | Sale | 24,428 | $5.43 | 1,405,995 |
| Jun 9, 2026 | Madhav Vasanthavadaofficer: Chief Commercial Officer | Sale | 5,450 | $5.30 | 303,451 |
CongressHouse and Senate disclosures
Not reported.